Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1367061 | Bioorganic & Medicinal Chemistry Letters | 2007 | 6 Pages |
Abstract
A novel piperidine series of γ-secretase inhibitors, potentially useful for the treatment of Alzheimer’s disease, is disclosed. SAR investigation revealed the requirement for cis-stereochemistry of the substituents attached to the core, which resulted in the chair-like diaxial conformation of the piperidine ring. The series was optimized to provide inhibitors with IC50’s in the single-digit nanomolar range. Absolute stereochemistry of the active enantiomer was assigned.
Graphical abstractA novel piperidine series of γ-secretase inhibitors, potentially useful for the treatment of Alzheimer’s disease, is disclosed.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Dmitri A. Pissarnitski, Theodros Asberom, Thomas A. Bara, Alex V. Buevich, John W. Clader, William J. Greenlee, Henry S. Guzik, Hubert B. Josien, Wei Li, Michael McEwan, Brian A. McKittrick, Terry L. Nechuta, Eric M. Parker, Lisa Sinning,